**Core Concept**
Neonatal hypothyroidism screening is a public health program aimed at early detection and treatment of congenital hypothyroidism, a condition characterized by inadequate production of thyroid hormones in newborns. This condition can lead to intellectual disability, growth retardation, and other developmental issues if left untreated.

**Why the Correct Answer is Right**
Neonatal hypothyroidism screening is the most common neonatal disorder screened due to its high prevalence and potential for severe consequences if untreated. The screening test typically involves a blood test to measure the level of thyroid-stimulating hormone (TSH) in the newborn's blood. Elevated TSH levels indicate hypothyroidism, which can be treated with thyroid hormone replacement therapy. Early detection and treatment can prevent long-term complications and ensure normal growth and development.

**Why Each Wrong Option is Incorrect**
**Option A:** Neonatal hypothyroidism is the correct answer, making this option incorrect by definition.
**Option B:** Neonatal hyperthyroidism is rare and not commonly screened for in newborns.
**Option C:** Hemoglobinopathies, such as sickle cell disease and thalassemia, are indeed screened for in newborns, but not as commonly as neonatal hypothyroidism.
**Option D:** Congenital dislocation of the hip is a musculoskeletal condition that is screened for through physical examination and ultrasound, but not through blood tests like neonatal hypothyroidism screening.

**Clinical Pearl / High-Yield Fact**
The American Academy of Pediatrics recommends neonatal hypothyroidism screening for all newborns, as early detection and treatment can significantly improve outcomes and prevent long-term complications.

✓ Correct Answer: A. Neonatal hypothyroidism